Mediation analyses
Analyses of the extent to which gene expression (X) may mediate the association between genotype (G) and diabetes (D) were conducted in the FIND samples in which gene expression had been measured in peripheral blood (N =1,416) . These analyses were conducted by the Sobel method (21) in which the following regression models were fit: D = cG + Σ 1
(1) X = aG + Σ 2 (2) D = bX + c′G + Σ 3
where Σ i represent the intercept and covariates of interest for each equation. Equations 1 and 3 were fit by logistic regression, while equation 2 was fit by linear regression. The mediation effect was taken as ab, and its standard error (21) as:
The standard errors for a and b (SE a , SE b ) were adjusted by the genomic control procedure to account for population stratification as described in the text. The percentage mediation, or the percentage of the genotypic effect on diabetes potentially explained by its effect on expression, was calculated as (22):
The primary mediation analyses were conducted for the SLC16A11 rs75493593 variant and RNASEK expression, as there is consistent evidence across multiple tissues that this is an eQTL (see text). However, the theoretical distribution of the mediation test is a complex function of the individual associations and to interpret these results in a genomic context, we also analyzed the additional 41 established type 2 diabetes genes typed in the FIND participants. In addition to rs75493593, 6 of the variants, rs10906115 (CDC123), rs2237892 (KCNQ1), rs231362 (KCNQ1), rs8050136 (FTO), rs4607517 (GCK), and rs3923113 (GRB14), were nominally associated (P <0.05) with diabetes in this sample. These 7 SNPs were then tested for association with all 15,854 transcripts genome-wide to identify potential eQTLs. EQTLs identified with nominal P <0.005 were further subjected to mediation analysis. This threshold was chosen to represent associations of comparable magnitude to the rs75493593-RNASEK eQTL and not to identify robust eQTL associations. To correct for multiple comparisons across all 110,978 SNP-transcript pairs, we also calculated the false discovery rate (23). Among the 85 potential eQTLs identified with nominal P <0.005, only 4 had P <0.05 for mediation and the strongest result was for the rs75493593-RNASEK eQTL. These results demonstrate that the pattern of associations is consistent with partial mediation of the rs75493593-diabetes association by a genotypic effect on RNASEK transcription, and they show that the pattern of mediation is stronger than expected for eQTL identified across the transcriptome with other diabetes associated variants of comparable effect.
Supplementary Figure 1.
( † P-values for the SWAI sample were adjusted for age, sex, birth-year, admixture estimate, and American Indian heritage. P-values for the FIND sample were adjusted for age, sex, admixture estimate, and tribal membership; the P-values were then adjusted by genomic control to account for any relatedness or population stratification. P-values for the SHS sample were adjusted for age, sex, admixture estimate, and study center.
‡ OR, odds ratios are given per copy of the A allele.
Supplementary Table 4. Distribution of participants according to diabetes status and rs75493593 genotype stratified by BMI category
Freq (A) is the frequency of the A allele. *P <0.05 for difference in BMI. † P-values were adjusted for age, sex, family membership, percent body fat, andAmerican Indian heritage.
Supplementary
‡ P-value was adjusted for age, sex, family membership, percent body fat, American Indian heritage, 30 min glucose, and glucose uptake rate during low dose insulin stimulation.
§ P-value was adjusted for age, sex, family membership, percent body fat, American Indian heritage, and glucose uptake rate during low dose insulin stimulation.
|| P-value was adjusted for age, sex, fat mass, fat free mass, family membership, American Indian heritage, and movement. ¶ P-values were adjusted for age, sex, family membership, percent body fat, American Indian heritage, and energy balance.
# Analysis was restricted to individuals with normal glucose tolerance: N (males/females) = 143 (97/46), 168 (103/65), and 69 (40/29) for C/C, C/A, and A/A, respectively. Mean ages (yrs) = 26.6 ± 5.8, 26.1 ± 5.8, and 28.8 ± 6.6 for C/C, C/A, and A/A, respectively. ** Beta values are given per copy of the A allele. EMBS, estimated metabolic body size.
Supplementary Table 7. SIFT scores for the 4 SLC16A11 missense variants
Of the 42 established type 2 diabetes-susceptibility variants, 7 variants, rs10906115 (CDC123), rs2237892 (KCNQ1), rs231362 (KCNQ1), rs75493593 (SLC16A11), rs8050136 (FTO), rs4607517 (GCK), and rs3923113 (GRB14) were nominally significant with type 2 diabetes in the FIND subjects (N = 1,416, data not shown). These 7 variants were selected for the eQTL analyses. The analyses were conducted using whole blood genome-wide expression data from the FIND subjects. Associations between each of the 7 variants and gene expression was examined for transcripts (N = 15,854) that were expressed above background as assessed by a χ2 tail test, that mapped to unique locations, and that were free of variants located in probe set binding sites according to ReMOAT annotation. * Positions (Mb) are from build 37 and for the transcripts are taken as the mid-point.
† The distance between the variant and transcript if located on the same chromosome.
‡ Beta is the effect size and is shown in SD units per diabetes risk allele.
§ P-values were calculated with genomic control; results were adjusted for age, sex, and America Indian heritage.
# Benjamini-Hochberg false discovery rate calculated across all 110,978 SNP-transcript pairs.
